by Market Overview:
Bioactive peptides are peptides that have a positive impact on body functions or conditions and may ultimately influence human health. They have antimicrobial, antihypertensive, immunomodulatory, and opioid effects.
Market key trends:
One of the key trends in the bioactive peptide market is rising health awareness among consumers. Consumers are increasingly becoming aware of diet and lifestyle practices for improved health outcomes. This has increased demand for functional foods and nutraceuticals containing bioactive peptides known for various health benefits like regulating blood pressure, boosting immunity, etc. Another key trend is growing research and development activities by companies for the development of new peptides and their applications. Major companies are investing heavily in R&D to develop innovative products.
The bioactive peptides market is witnessing growth due to the increasing demand for functional food and drinks. The demand for immunity-boosting and nutrition-enriched foods has grown significantly during the pandemic. Leading food companies are increasingly incorporating bioactive peptides into various food products due to their identified health benefits. Some key benefits of bioactive peptides include enhanced muscle protein synthesis, reduced inflammation, improved heart health, and modulation of satiety signals.
The global Bioactive Peptide Market Growth is estimated to be valued at US$ 9.8 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strengths: Bioactive peptides offer specific health advantages compared to other ingredients. They have good solubility and stability.
Weaknesses: High production costs involved with extracting and purifying peptides from sources. Limited research on long-term effects of consuming certain peptides.
Opportunities: Growing demand for functional foods provides an opportunity to introduce more food products containing bioactive peptides. Scope for further research to utilize peptides for treating disorders.
Threats: Stringent safety and quality regulations for new ingredients. Competition from other functional ingredients that provide similar benefits.
Key Takeaways
The global bioactive peptide market size was valued at US$ 9.8 Mn in 2023. The market is expected to grow at a CAGR of 9.4% from 2023 to 2030 due to the increasing demand for nutrition-enriched functional foods and beverages.
The Asia Pacific region dominated the global market in 2023 and is projected to be the fastest-growing regional market during the forecast period. Countries like China, Japan, and India are major consumers as well as producers of bioactive peptides.
Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
